Kedrion Biopharma Gains FDA Approval for QIVIGY in PI Treatment
September 29, 2025
Kedrion Biopharma has announced that it has secured FDA approval for QIVIGY, intended for adult patients suffering from primary humoral immunodeficiency (PI). This group of